Founded in 2019 and based in Barcelona, Ona Therapeutics is a clinical-stage biotechnology company developing innovative antibody drug conjugates to treat advanced cancers. The company focuses on identifying novel therapeutic targets based on the biology of treatment-resistant tumors, with the aim of delivering new options for patients with limited treatment alternatives.
Team
Venture Capital
Status
Current
Geography
Europe
Financing Round
Financing round - Series B
Segment
Therapeutic Intervention
Entry Date
2026
Key Figures
Current
Status
2019
Creation Date
35
Number of Employees
2026
Investment Date
Mérieux Innovation 2
Fund Name